ARTICLE | Company News
Novacea, Pierre Fabre Group deal
August 1, 2005 7:00 AM UTC
Pierre Fabre granted Novacea North American rights to develop and commercialize oral vinorelbine to treat cancer. Pierre Fabre retains rights in Europe and other markets, where the oral semi-synthetic...